Article info
PDFLetters to JMG
Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome
- Correspondence to: Dr T Frebourg Inserm U614, Faculty of Medicine, 22 Boulevard Gambetta, 76183 Rouen, France; frebourg{at}chu-rouen.fr
Citation
Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome
Publication history
- Received August 18, 2005
- Accepted October 18, 2005
- Revised October 14, 2005
- First published October 28, 2005.
Online issue publication
April 27, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2006 Journal of Medical Genetics